Edgestream Partners L.P. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 7,119 shares of the company’s stock, valued at approximately $2,160,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Commonwealth Equity Services LLC raised its position in shares of HCA Healthcare by 2.1% during the second quarter. Commonwealth Equity Services LLC now owns 24,607 shares of the company’s stock valued at $7,468,000 after buying an additional 495 shares during the last quarter. Shelton Capital Management raised its position in shares of HCA Healthcare by 59.3% during the second quarter. Shelton Capital Management now owns 22,816 shares of the company’s stock valued at $6,924,000 after buying an additional 8,493 shares during the last quarter. Great Lakes Advisors LLC bought a new stake in HCA Healthcare in the second quarter worth $1,466,000. Trustmark National Bank Trust Department increased its position in HCA Healthcare by 1.7% in the second quarter. Trustmark National Bank Trust Department now owns 7,702 shares of the company’s stock worth $2,337,000 after purchasing an additional 129 shares during the last quarter. Finally, Private Advisor Group LLC increased its position in HCA Healthcare by 288.4% in the second quarter. Private Advisor Group LLC now owns 11,730 shares of the company’s stock worth $3,510,000 after purchasing an additional 8,710 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on HCA shares. Raymond James reduced their price target on shares of HCA Healthcare from $320.00 to $280.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 25th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $315.00 price objective on shares of HCA Healthcare in a research note on Thursday, September 14th. Sanford C. Bernstein dropped their price objective on shares of HCA Healthcare from $345.00 to $294.00 in a research note on Tuesday, October 10th. Wells Fargo & Company dropped their price objective on shares of HCA Healthcare from $267.00 to $254.00 and set an “equal weight” rating for the company in a research note on Thursday, October 26th. Finally, The Goldman Sachs Group dropped their price objective on shares of HCA Healthcare from $329.00 to $281.00 and set a “buy” rating for the company in a research note on Monday, October 30th. Two investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $296.59.
HCA Healthcare Stock Up 2.5 %
NYSE:HCA opened at $246.38 on Monday. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $304.86. The company has a 50-day moving average of $242.32 and a 200 day moving average of $266.42. The firm has a market cap of $65.95 billion, a PE ratio of 12.12, a price-to-earnings-growth ratio of 1.38 and a beta of 1.66. The company has a debt-to-equity ratio of 103.06, a current ratio of 1.15 and a quick ratio of 0.99.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 24th. The company reported $3.91 earnings per share for the quarter, missing analysts’ consensus estimates of $3.97 by ($0.06). HCA Healthcare had a return on equity of 2,040.32% and a net margin of 9.05%. The business had revenue of $16.21 billion during the quarter, compared to analysts’ expectations of $15.77 billion. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 18.18 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 28th. Investors of record on Thursday, December 14th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Wednesday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.81%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Five stocks we like better than HCA Healthcare
- Industrial Products Stocks Investing
- 2 stocks that under-promised and over-delivered on their earnings
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 2 overlooked stocks that crushed earnings but traded lower
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 stocks that crushed earnings estimates and still tanked
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.